Congress expands treatment for pregnant women with substance use disorders
S. 1004 — Pregnant and Postpartum Women Treatment Reauthorization Act · Filed by Ben Luján (D-NM) · 4 cosponsors · Introduced Mar 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill reauthorizes and expands federal funding for residential treatment programs serving pregnant and postpartum women with substance use disorders. It increases annual appropriations from $29.9 million (2019–2023) to $38.9 million (2025–2029), adds a requirement that programs describe outreach plans targeting women disproportionately affected by maternal substance use disorder, and makes minor technical clarifications to the underlying statute.
Why we flagged it
The bill's sole operative function is to reauthorize and increase funding for an existing federal program supporting residential treatment for pregnant and postpartum women with substance use disorders. It is a straightforward public health appropriations measure with no hidden mechanisms or private carve-outs.
What the text implies
- Increased funding may improve maternal health outcomes and reduce neonatal abstinence syndrome (NAS) cases, with downstream benefits for child welfare and reduced NICU costs.
- Requirement for outreach plans targeting disproportionately impacted women may improve equity in access to treatment, though effectiveness depends on implementation and enforcement.
The full analysis lists 3 implications of this text.
Who stands to gain
residential treatment facilities serving pregnant and postpartum women; substance use disorder treatment providers; community health centers and federally qualified health centers (FQHCs) operating maternal treatment